A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Status:
Completed
Trial end date:
2008-02-11
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study designed to test the ability of investigational study drug
ARRY-371797 to reduce pain either perioperatively or postoperatively in a third molar
extraction pain model, and to further evaluate the drug's safety. Approximately 150 subjects
from the US will be enrolled in this study.